您的位置: 首页 > 农业专利 > 详情页

Canine tumor drug
专利权人:
東レ株式会社
发明人:
岡野 文義
申请号:
JP1998220074
公开号:
JP4915828B2
申请日:
1998.08.04
申请国别(地区):
JP
年份:
2012
代理人:
摘要:
PROBLEM TO BE SOLVED: To obtain a new dog interleukin 18 having an activity for inducing a factor acting on a canine leukocyte to intensify the expression of an antiviral activity factor and class II MHC existing on a canine tumor cell or the like, and useful as a treating agent for canine immunological diseases or the like. SOLUTION: A new canine interleukin 18 acting on a canine leukocyte to give at least one among an activity for inducing a factor for intensifying the expression of an antiviral activity factor and class II MHC existing on a canine tumor cell, an activity for stimulating the growth of canine lymphocytes, an activity for intensifying the expression of Fas ligand existing on a canine lymphocyte and a canine tumor cell, an activity for damaging and killing a canine tumor cell, an activity for reducing the size of tumors occurred on a dog body, an activity for activating a canine leukocyte to suppress canine allergy, and the like. The substance is useful as a treating agent for canine immunological diseases or the like. It is obtained by expressing a recombinant vector including a DNA encoding the precursor protein of interleukin 18 and a DNA encoding an interleukin-1 β converting enzyme.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/
相关发明人
相关专利

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充